Ir a las Transacciones
Salud

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

Vivo Diagnóstico is a large provider of diagnostic imaging services. It owns a network of clinics located in Andalusia, Madrid and Aragon and offers services throughout Spain, providing diagnostic imaging services in mobile units, outsourced diagnostic services for hospitals and teleradiology services.

For over 25 years, the private equity firm NEXXUS-IBERIA has partnered with entrepreneurs and management teams to consolidate and accelerate the growth of their businesses.

Oaklins’ team in Spain advised Vivo Diagnóstico on all aspects of the transaction, from the design to the execution, negotiation and closing of the deal.

Partes

Contáctese con el equipo de la transacción

Mark Parson

Socio Director
Madrid, España
Oaklins SOCIOS

José Falgás

Socio
Madrid, España
Oaklins SOCIOS

Transacciones relacionadas

Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market
Servicios Financieros | Salud

Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market

Doverie United Holding has successfully completed the sale of United Health Insurance Fund Doverie (Doverie) to Generali CEE Holding.

Conozca más
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Salud

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Conozca más
Afric Phar has been acquired by Pharma Capital
Salud

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

Conozca más